GLOW Study: Effects of Triple Protein in Women

ConditionHealthy Women
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-60
SponsorUniversity of North Carolina, Chapel Hill

About this trial

This single-site, randomized, blinded, placebo-controlled study will evaluate whether 4 weeks of daily Triple Support Protein powder improves glycemic control and overall well-being in healthy women aged 30-60 years. Participants will undergo baseline testing (DXA, fasting blood, standardized meal test with 2-hour glucose and insulin sampling), complete one acute supervised dose, and then consume a daily supplement for 4 weeks. During the final 14 days, participants will wear a continuous glucose monitor. Outcomes include postprandial glucose AUC, insulin sensitivity, and body composition.

Eligibility criteria

Qualifiers

Females aged 30-60 years.

BMI 18.5-40 kg/m².

Recreationally active (≥30 min/wk moderate intensity exercise).

Healthy and free from disease per health history questionnaire.

Disqualifiers

Currently supplementing whey protein.

Pregnant or nursing.

Lactose intolerant.

Currently using creatine monohydrate.

Trial design

Treatments tested in this trial

  • Triple protein support
  • Placebo

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators